Everence Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
Everence Capital Management's CLB Position: Q3 2025 in Review
Everence Capital Management sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 13,420 shares — an estimated $155K sold.
Everence Capital Management first reported a position in CLB in Q2 2020 and held it in 18 quarters. The position peaked at $1.54M in Q2 2021. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.
- Everence Capital Management reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
- Everence Capital Management sold 13,420 Core Laboratories shares in Q3 2025, an estimated $155K.
- Everence Capital Management first reported a position in Core Laboratories in Q2 2020 and held it in 18 quarters.
- Everence Capital Management's Core Laboratories position peaked at $1.54M in Q2 2021.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.
Based on Everence Capital Management's 13F filing for Q3 2025, filed 1 Oct 2025.